Cargando…
The effect of CELLFOOD(TM) on radiotherapy or combined chemoradiotherapy: preclinical evidence
BACKGROUND: Based on previous observations that the nutraceutical CELLFOOD™ (CF), the ‘physiological modulator’ that aimed to make oxygen available ‘on demand’, inhibits the growth of cancer cells, this study was designed to investigate the role of CF in the regulation of hypoxia-inducible factor 1...
Autores principales: | Nuvoli, Barbara, Amadio, Bruno, Cortese, Giancarlo, Benedetti, Serena, Antoniani, Barbara, Soriani, Antonella, Carosi, Mariantonia, Strigari, Lidia, Galati, Rossella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792276/ https://www.ncbi.nlm.nih.gov/pubmed/31662796 http://dx.doi.org/10.1177/1758835919878347 |
Ejemplares similares
-
Metabolism modifications and apoptosis induction after Cellfood™ administration to leukemia cell lines
por: Catalani, Simona, et al.
Publicado: (2013) -
CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways
por: Nuvoli, Barbara, et al.
Publicado: (2014) -
Correction: CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways
por: Nuvoli, Barbara, et al.
Publicado: (2022) -
Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities
por: Nuvoli, Barbara, et al.
Publicado: (2021) -
Correction: Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities
por: Nuvoli, Barbara, et al.
Publicado: (2023)